R3 Vascular Announces 1st Patient Treated in ELITE-BTK Trial
22 Apr 2025 //
GLOBENEWSWIRE
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial
04 Nov 2024 //
GLOBENEWSWIRE
R3 Vascular Appoints Josh Smale As VP Of Clinical And Scientific Affairs
09 Jul 2024 //
GLOBENEWSWIRE
R3 Vascular $87M Series B, New CEO Christopher Owens
09 May 2024 //
GLOBENEWSWIRE